0001127602-11-015215.txt : 20110505 0001127602-11-015215.hdr.sgml : 20110505 20110505102636 ACCESSION NUMBER: 0001127602-11-015215 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110503 FILED AS OF DATE: 20110505 DATE AS OF CHANGE: 20110505 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jensen Peder CENTRAL INDEX KEY: 0001518724 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23186 FILM NUMBER: 11813019 MAIL ADDRESS: STREET 1: 15 SKYLINE DRIVE CITY: HAWTHORNE STATE: NY ZIP: 10532 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOCRYST PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000882796 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 621413174 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2190 PARKWAY LAKE DR CITY: BIRMINGHAM STATE: AL ZIP: 35244 BUSINESS PHONE: 2054444600 MAIL ADDRESS: STREET 1: 2190 PARKWAY LAKE DR CITY: BIRMINGHAM STATE: AL ZIP: 35244 4 1 form4.xml PRIMARY DOCUMENT X0303 4 2011-05-03 0000882796 BIOCRYST PHARMACEUTICALS INC BCRX 0001518724 Jensen Peder 4505 EMPEROR BLVD. SUITE 200 DURHAM NC 27703 1 Automatic Stock Option Grant 3.62 2011-05-03 4 A 0 2083 0 A 2011-05-12 2021-05-03 Common Stock 0 2083 D Automatic grant pursuant to the BioCryst Pharmaceuticals, Inc. Stock Incentive Plan (the "Plan"). Pursuant to the Plan, this grant will fully vest on the date of the BioCryst Pharmaceuticals, Inc. annual meeting of stockholders. /s/ Peder Jensen, M.D. 2011-05-04